Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Completed · Not applicable

Conditions studied: Opioid-Related Disorders

In brief

Buprenorphine is a treatment for opioid dependence. Naloxone is given in addition to buprenorphine in order to limit the abuse potential that is commonly associated with buprenorphine. The purpose of this study is to examine the effects of buprenorphine/naloxone when given through different routes and at different doses.

Key facts

Study ID

NCT00134914

Run by

National Institute on Drug Abuse (NIDA)

People needed

10

Starts

1996-08-01

Expected to finish

1998-05-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Currently opioid dependent
• In good health, as determined by a pre-participation medical examination
• Seeking and eligible for methadone maintenance or detoxification treatment

You may not qualify if…

• Significant medical or psychiatric illness, other than drug dependence

Where it is running

• Johns Hopkins University (BPRU) Bayview Campus — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.